Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2016Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
5Annual filing director officer or owner of more than ten percent.Feb 12, 2016Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
5Annual filing director officer or owner of more than ten percent.Feb 12, 2016Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
5Annual filing director officer or owner of more than ten percent.Feb 12, 2016Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
5Annual filing director officer or owner of more than ten percent.Feb 12, 2016Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2016Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2016Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
8-KReport of unscheduled material events or corporate eventJan 7, 2016Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
8-KReport of unscheduled material events or corporate eventJan 7, 2016Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
3Initial filing by director officer or owner of more than ten percent.Jan 6, 2016Open Initial filing by director officer or owner of more than ten percent. in HTML.Open Initial filing by director officer or owner of more than ten percent. in DOC file.Open Initial filing by director officer or owner of more than ten percent. in PDF file.Open Initial filing by director officer or owner of more than ten percent. in XLS file.
4Statement of changes in beneficial ownership of securitiesJan 6, 2016Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
1-25      26-50      51-75      76-100      101-125      126-136

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information